Basel Medical Group Ltd Ordinary Shares (BMGL) vs Lexaria Bioscience Corp. (LEXX)
A side-by-side comparison of Basel Medical Group Ltd Ordinary Shares and Lexaria Bioscience Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.20HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
LEXX
Lexaria Bioscience Corp.
$2.90HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
Total return — BMGL vs LEXX
growth of $100 · dividends reinvested · last 2yBMGL -94.1% (-75.6%/yr)LEXX -87.5% (-64.7%/yr)LEXX compounded faster over this window
BMGL LEXX
BMGL vs LEXX: by the numbers
- •BMGL is the larger company ($5M vs $5M market cap).
- •Both run net losses; BMGL's is the smaller (-106.78% vs -3985.58% net margin).
Metrics side by side
Valuation
| Metric | BMGL | LEXX |
|---|---|---|
| P/S ratio | N/A | 24.70 |
| P/B ratio | 1.03 | 1.01 |
Profitability
| Metric | BMGL | LEXX |
|---|---|---|
| Gross margin | 77.68% | 100.00% |
| Operating margin | -19.28% | -1683.01% |
| Net margin | -106.78% | -3985.58% |
| ROE | -248.66% | -163.18% |
| ROIC | -35.07% | -175.26% |
Growth (annualized)
| Metric | BMGL | LEXX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.92% |
| Total return CAGR (5Y) | N/A | -50.86% |
Go deeper
Dig into the metrics
Basel Medical Group Ltd Ordinary Shares ROELexaria Bioscience ROEBasel Medical Group Ltd Ordinary Shares operating marginLexaria Bioscience operating marginBasel Medical Group Ltd Ordinary Shares revenue growthLexaria Bioscience revenue growthBasel Medical Group Ltd Ordinary Shares free cash flowLexaria Bioscience free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.